Latest Commercialization News

Artrya Limited marked its first full year of US commercial operations with a $25.18 million loss, driven by regulatory clearances, customer contracts, and an $80 million capital raise.

ReNerve Ltd (ASX:RNV) reported an 80% year-on-year revenue increase in Q4 FY26, backed by expanding product lines and a $5 million funding facility. The company is advancing FDA approvals and growing its global distribution footprint, targeting a rapidly expanding $6.19 billion nerve repair biomaterials market.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.

ImpediMed has secured FDA 510(k) clearance for its SOZO Digital Health Platform to assess sarcopenia risk, marking it as the only FDA-cleared bioimpedance spectroscopy solution for this clinical application. This clearance enables clinicians to non-invasively monitor muscle loss in cancer and chronic disease patients, potentially improving treatment outcomes.

PhosCo Ltd’s maiden drilling at the KH prospect within its Gasaat Phosphate Project in Tunisia has delivered wide, high-grade phosphate intersections close to the proposed plant, promising to enhance early project economics.

Kinetiko Energy’s South African subsidiary has locked in a $1.26 million cash agreement with Mulilo, resolving land-use conflicts and gaining a potential gas supply edge for a major wind energy project.

Solvar Limited posted a 6.2% decline in statutory net profit for FY26 to $29.5 million, while normalised earnings rose 7.5%. The lender declared a 19.5 cents fully franked dividend and expanded its Australian loan book by 10.5%, driven by growth in commercial lending.

Environmental Clean Technologies has secured A$10.6 million in a placement to fast-track commercialisation of its Flash Joule Heating platform and MXene manufacturing, backed by a strategic acquisition and feedstock supply.

ION Video has appointed two seasoned executives to its board and elevated Anthony Baker to Managing Director as it sharpens focus on scaling its patented video technology. Founder Finbar O’Hanlon steps back from the board to concentrate on innovation and expanding the company’s IP portfolio.

Equus Energy's Pre-FEED study confirms a robust, phased development plan for its Equus Gas Project, targeting LNG, domestic gas, and condensate production with strong economic returns.

Entropy Neurodynamics has partnered with BioCina to establish GMP manufacturing for its intravenous psilocin formulation TRP-8803, a critical step toward late-stage clinical trials and commercialisation.